Identification of Oncolytic Avian Reovirus Receptors in B16-F10 Cells and the Signaling-Mediated Pathways Involved in Viral Entry
Viruses · 2026
DOI: 10.3390/v18030350 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Chao-Yu Hsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Tungs' Taichung MetroHarbor Hospital, Taichung 435, Taiwan. Hauptthemen laut MEDLINE: Orthoreovirus, Avian, Virus Internalization, Receptors, Virus, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of Taiwan, the Ministry of Education (MOE) in Taiwan, Taichung Veterans General Hospital.
Abstract (Originalsprache)
Avian reovirus (ARV) is a major poultry pathogen recently recognized for its potential as an oncolytic virus that selectively infects and kills cancer cells without harming healthy human cells. However, the receptors mediating ARV entry into cancer cells remain unclear. Using mouse melanoma B16-F10 cells as a model, this study identified ARV-binding receptor candidates through viral overlay protein binding assay (VOPBA), SDS-PAGE, and LC-MS/MS analysis. Plaque-forming assays (PFAs) evaluated viral replication efficiency, while co-immunoprecipitation (Co-IP) and proximity ligation assay (PLA) confirmed direct interactions between viral σC and host receptor proteins. Functional assays using shRNA knockdown and antibody blocking demonstrated that inhibition of Plg-RKT expression markedly reduced ARV infection. Western blot analysis revealed that ARV binding to Plg-RKT activates Src and p38 MAPK signaling pathways, which promote caveolin-1 phosphorylation and caveolae-mediated endocytosis. These findings identify Plg-RKT as a crucial receptor mediating ARV σC binding and entry into B16-F10 melanoma cells. Furthermore, activation of Src-p38 MAPK signaling was shown to be essential for viral internalization. This study elucidates the molecular mechanism underlying ARV entry into melanoma cells and provides valuable insight for improving the selectivity and therapeutic potential of ARV as an oncolytic virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, Tungs' Taichung MetroHarbor Hospital, Taichung 435, Taiwan.
- Institute of Molecular Biology, National Chung Hsing University, Taichung 402, Taiwan.
- The IEGG and Animal Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan.
- Department of Medical Research, Taichung Veterans General Hospital, Taichung 407, Taiwan.
- Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.
- Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.
ORCID-Profile: Jyun-Yi Li, Tsai-Ling Liao, Yi-Ying Wu, Yu-Kang Chang, Muhammad Munir, Hung-Jen Liu
Förderung
- Ministry of Science and Technology of Taiwan
- the Ministry of Education (MOE) in Taiwan
- Taichung Veterans General Hospital
Zitieren
APA
Hsu, C. Y., Tu, B. Y., Li, J. Y., Liao, T. L., Wu, Y. Y., Lin, C. Y., Chang, Y. K., Munir, M., & Liu, H. J. (2026). Identification of Oncolytic Avian Reovirus Receptors in B16-F10 Cells and the Signaling-Mediated Pathways Involved in Viral Entry. Viruses. https://doi.org/10.3390/v18030350
Vancouver
Hsu CY, Tu BY, Li JY, Liao TL, Wu YY, Lin CY, et al. Identification of Oncolytic Avian Reovirus Receptors in B16-F10 Cells and the Signaling-Mediated Pathways Involved in Viral Entry. Viruses. 2026. doi:10.3390/v18030350
BibTeX
@article{Hsu2026,
author = {Hsu, Chao-Yu and Tu, Bo-Yan and Li, Jyun-Yi and Liao, Tsai-Ling and Wu, Yi-Ying and Lin, Chia-Ying and Chang, Yu-Kang and Munir, Muhammad and Liu, Hung-Jen},
title = {Identification of Oncolytic Avian Reovirus Receptors in B16-F10 Cells and the Signaling-Mediated Pathways Involved in Viral Entry},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18030350}
}
EUVIMED